Your browser doesn't support javascript.
loading
Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia.
Roboz, Gail J; Montesinos, Pau; Selleslag, Dominik; Wei, Andrew; Jang, Jun-Ho; Falantes, Jose; Voso, Maria T; Sayar, Hamid; Porkka, Kimmo; Marlton, Paula; Almeida, Antonio; Mohan, Sanjay; Ravandi, Farhad; Garcia-Manero, Guillermo; Skikne, Barry; Kantarjian, Hagop.
Afiliación
  • Roboz GJ; Weill Medical College of Cornell University & New York-Presbyterian Hospital, New York, NY, USA.
  • Montesinos P; Hospital Univeritari I Politecnic La Fe de Valencia, Valencia, Spain.
  • Selleslag D; AZ Sint-Jan AV, Brugge, Belgium.
  • Wei A; The Alfred Hospital & Monash University, Melbourne, Australia.
  • Jang JH; Samsung Medical Center, Seoul, South Korea.
  • Falantes J; Hospital Universitario Virgen del Rocio & Instituto de Biomedicinia de Sevilla, Seville, Spain.
  • Voso MT; Universita Cattolica del Sacro Cuore, Rome, Italy.
  • Sayar H; Indiana University Cancer Center, Indianapolis, IN, USA.
  • Porkka K; Helsinki University Central Hospital, Helsinki, Finland.
  • Marlton P; Princess Alexandra Hospital, University of Queensland School of Medicine, Brisbane, Australia.
  • Almeida A; Instituto Portugues de Oncologia Francisco Gentil, Lisbon, Portugal.
  • Mohan S; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Ravandi F; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Garcia-Manero G; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Skikne B; Celgene Corporation, Overland Park, KS, USA.
  • Kantarjian H; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Future Oncol ; 12(3): 293-302, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26785287
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Azacitidina / Leucemia Mieloide Aguda / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials Límite: Humans / Middle aged Idioma: En Revista: Future Oncol Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Azacitidina / Leucemia Mieloide Aguda / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials Límite: Humans / Middle aged Idioma: En Revista: Future Oncol Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos